Health Trials

Facioscapulohumeral Muscular Dystrophy 2

2

Review clinical trials related to Facioscapulohumeral Muscular Dystrophy 2. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)

Participants needed: 200
Trial details
Phase: Phase 3Age: 16-70Biological sex: AllType: InterventionalSponsor: Avidity Biosciences, Inc.Updated: May 29, 2026Locations: 46
Eligibility criteria

Clinical and genetic diagnosis of FSHD1 or FSHD2 [+2]

Breastfeeding, pregnancy, or intent to become pregnant during the study [+5]

Read more
Status: Recruiting

BetterLife FSHD: A Patient-driven Health and Research Platform

BetterLife FSHD is a registry platform built to support people living with FSHD. It connects patients with personalized resources, tools, and research opportunities that match their health experiences and needs. At the same time, BetterLife collects secure health and experience data from patients to support research. This data is shared with researchers to help better understand FSHD and work toward improved care, treatments, and outcomes for the community. Learn more and enroll at: www.BetterLifeFSHD.org

Participants needed: 5,000
Trial details
Age: 1+Biological sex: AllType: ObservationalSponsor: FSHD SocietyUpdated: Feb 20, 2026Locations: 1Duration: 100 Years
Eligibility criteria

Individuals with a clinical or genetic diagnosis of FSHD, or individuals with a... [+4]

Individuals residing outside the United States or its territories [+1]

Read more